Safa Systems Allots 23.9 Lakh Shares to Promoters for Rs 4.89 Crore

OTHER
Whalesbook Corporate News Logo
AuthorAnanya Iyer|Published at:
Safa Systems Allots 23.9 Lakh Shares to Promoters for Rs 4.89 Crore

Safa Systems & Technologies has completed a preferential allotment of 23.9 lakh equity shares to promoters and promoter group entities. The shares were issued at Rs 20.47 per share, raising approximately Rs 4.89 crore in capital. This transaction increases the promoter group's shareholding from 44.35% to 49.21%, signaling promoter confidence in the company's future growth path.

Safa Systems Raises Rs 4.89 Crore via Promoter Preferential Allotment

  • Capital Raised: Rs 4.89 crore
  • Shares Allotted: 23,90,000 equity shares

Reader Takeaway: Promoter stake rise to 49.21% boosts confidence, but fund utilization remains the key operational metric to monitor.

What just happened

Safa Systems & Technologies Ltd has finalized a preferential allotment of 23,90,000 fully paid-up equity shares. The board approved the issuance on October 5, 2026, at a price of Rs 20.47 per share, which includes a premium of Rs 10.47 over the face value of Rs 10.

Why this matters

The infusion of Rs 4.89 crore strengthens the company's capital base. By issuing these shares exclusively to eight entities within the promoter and promoter group, the company has effectively consolidated its ownership structure, increasing the group's total holding from 44.35% to 49.21%.

The backstory

The allotment follows necessary authorizations secured during the company's 5th Annual General Meeting on September 11, 2026. The shares are issued under SEBI ICDR guidelines and will rank pari passu with existing equity shares.

What changes now

The company’s total paid-up share capital has increased from 2,49,77,550 shares to 2,73,67,550 shares. Safa Systems will now apply for the listing and trading approval for these new shares on the stock exchange.

Risks to watch

Investors should keep a close eye on how the company plans to utilize the Rs 4.89 crore infusion. Efficient deployment of this capital to drive operational growth is essential to justify the dilution to minority shareholders.

What to track next

The next key development will be the formal listing and trading of the newly issued shares on the BSE, followed by the company’s subsequent quarterly disclosures regarding capital usage.

Disclaimer: This article is published for informational purposes only. This is not a buy sell recommendation.